Looking to publish in European Clinical Respiratory Journal? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowEuropean Clinical Respiratory Journal is a peer-reviewed international open access journal that publishes studies on respiratory diseases. It focuses on the immunology and pathophysiology of the respiratory system and covers clinical and educational content including epidemiology, clinical trials, diagnostics, treatment guidelines, literature reviews, case presentations, letters to the editor, and expert opinions. The journal accepts original articles, short communications and reviews, and operates a double-anonymized peer review policy.
Looking to publish in European Clinical Respiratory Journal? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
European Clinical Respiratory Journal accepts the following article types. Click on an article type to view submission instructions.
Research Articles
Review Articles
Rapid Communication
Case Report
Editorials
Recent Publications
Mepolizumab treatment is associated with physical activity and cardiorespiratory fitness irrespective of endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyps: a randomised controlled trial
Tidemandsen Jens, Hostrup Morten, Homøe Anne-Sophie, Moesgaard Lukas, Aanæs Kasper, Meteran Howraman, Backer Vibeke
Adult reference values for spirometry, body plethysmography and diffusing capacity adjusted for sex, age, weight, height or arm span - the Danish lung function material (DALFUMAT) study
Jann Mortensen, Lars Kristensen, Mathias Munkholm, Birgitte Hanel, Jan Abrahamsen, Kirsten Sidenius, Bente Grønlund, Ole Hilberg, Niels Maltbæk, Ingrid Louise Titlestad, Ronald Dahl, Bo Martin Bibby, Sofie Nellemann Kryger, Ulla Møller Weinreich, Johannes Martin Schmid, Elisabeth Bendstrup, Jens Peder Dreyer Paludan, Charlotte Hyldgaard, Lisbeth Mariager Danielsen, Lene Sønderskov Dahl, Elin Jørgensen, Torben Tranborg Jensen, Tilde Kinket Ellingsgaard, Dan Fuglø, Peter Hovind, Ronan Martin Griffin Berg, Flemming Madsen
Lung abscess as an adverse effect of Risankizumab
Zarif Kazi, Stuart Jesin, Samir Ghimire, Toni-Ann Lewis, Thai Donenfeld, Kevin Clements, William Pascal
Long-term lung function trajectories in Swedish COVID-19 ICU survivors: a two-year follow-up study
Marta A. Kisiel, Emil Ekbom, Christer Janson, Össur Emilsson, Miklos Lipcsey, Robert Frithiof, Michael Marks-Hultström, Andrei Malinovschi
Short-term oral corticosteroid use and risk for major adverse cardiovascular events within one year in patients with chronic obstructive pulmonary disease, a Danish registry-based cohort study
Gertrud Baunsgaard-Pedersen, Barbara Bonnesen, Josefin Eklöf, Jens Ulrik Stæhr Jensen, Pradeesh Sivapalan
Frequently asked questions
How long does it take to publish?
12 days avg. from submission to first decision; 59 days avg. from submission to first post-review decision; 13 days avg. from acceptance to online publication.
Reformat to European Clinical Respiratory Journal using Livewrite PremiumWhat are the publication costs?
An Article Publishing Charge (APC) may apply. Authors may be able to publish at no cost to themselves or with a reduced APC through an open access agreement or membership, and discounts and waivers may be available for selected countries.
Reformat to European Clinical Respiratory Journal using Livewrite Premium